Implementation Laboratory

实施实验室

• 批准号: 10020384
• 负责人: AIMEE S JAMES
• 金额: $ 35.72万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-18 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10020384
• 关键词: Address; Cancer Center; Cancer Control; Cancer Control Research; Cancer Control Research Program; Catchment Area; Clinic; Clinical; Clinical Services; Collaborations; Communities; Community Developments; Community Health; County; Data; Disadvantaged; Evaluation; Evidence based practice; Feedback; Goals; Health system; Healthcare; Healthcare Systems; Illinois; Incubators; Information Systems; Intervention; Intervention Studies; Laboratories; Leadership; Malignant Neoplasms; Measurement; Medical; Methods; Missouri; Monitor; Needs Assessment; Outcome; Patient-Focused Outcomes; Patients; Policies; Population; Positioning Attribute; Program Evaluation; Provider; Public Health; Reporting; Research; Research Personnel; Resources; Rural; Rural Health; Science; Services; Site; Structure; System; Time; Underserved Population; Universities; Vision; Washington; Work; cancer health disparity; cancer prevention; community organizations; data management; data resource; evidence base; experience; health care service organization; health data; health disparity; implementation research; implementation science; improved; innovation; member; multidisciplinary; novel; programs; provider networks; social; social health determinants

PROJECT SUMMARY – Implementation Laboratory Background and vision. As an Advanced Center, the vision of the Washington University Implementation Science Center for Cancer Control (WU-ISCCC) is to conduct implementation research to help eliminate cancer disparities in rural and other disadvantaged communities. Goal. The Implementation Lab, hereafter called the Innovation Incubator, through Incubator Membership, a Data Management Unit, and a Practice Surveillance Unit, will work closely with the WU-ISCCC Research Program to facilitate implementation science research by connecting investigators to implementation sites in the Membership, convening community and clinical partners to review data and identify needs and priorities, and support evaluation of program outcomes. Aims. The Incubator will: Aim 1. Establish leadership structure and functions that enable and support rapid-cycle and innovative implementation science in cancer control. Aim 2. Sustain and develop additional research partnerships with a range of healthcare systems and organizations/agencies committed to innovative implementation science projects that address social determinants of health and reduce cancer disparities. Aim 3. Support data systems and resources to manage multi-site projects, collect rigorous data, and produce timely reports to the project leaders and the WU-ISCCC leadership. Aim 4. Cultivate a surveillance unit to report on progress toward reducing cancer disparities in the populations across Siteman Cancer Center's 82-county catchment area. Aim 5. Draw on real-time clinical service data from health systems within BJC Healthcare and the BJC Collaborative network to monitor policies, provider practices, patient outcomes and progress in reducing cancer disparities. Innovations and impact. The Incubator will work to fulfill the overall goal of the WU-ISCCC to build a rigorous, scientific evidence base for rapid-cycle implementation research to increase the reach, external validity, and sustainment of effective cancer control interventions. We will convene multi-sector partners to inform and act as settings for innovative and impactful research prioritizing rural and other underserved communities. The Incubator will provide statistical and data support for rigorous execution of pilot and methods studies coming out of the Research Program, supporting investigators from conceptualization and planning through dissemination. These linkages and activities of the Incubator and our diverse Membership will position the WU- ISCCC to accelerate the innovation, pace, and impact of implementation science for cancer control and reduce cancer health disparities in our region and nationwide.

项目摘要--执行实验室 背景和愿景。作为一个高级中心，华盛顿大学实施的愿景 癌症控制科学中心(WU-ISCCC)正在进行实施研究，以帮助消除 农村和其他弱势社区的癌症差异。 进球了。实施实验室，以下称为创新孵化器，通过孵化器成员资格， 数据管理股和一个实践监督股将与WU-ISCCC研究密切合作 通过将调查人员与实施地点联系起来，促进实施科学研究的计划 成员，召集社区和临床合作伙伴审查数据，确定需求和优先事项， 并支持对项目结果的评估。 目标。孵化器将： 目标1.建立能够支持和支持快速循环和创新的领导结构和职能 癌症控制中的实施科学。 目标2.维持和发展与一系列保健系统的更多研究伙伴关系 致力于创新实施科学项目的组织/机构，以解决社会问题 健康的决定因素和减少癌症差异。 目标3.支持数据系统和资源来管理多站点项目，收集严格的数据，并生成 及时向项目负责人和武钢总公司领导汇报。 目标4.建立一个监测单位，报告在减少人口癌症差距方面取得的进展 横跨西特曼癌症中心82个县的集水区。 目标5.利用来自BJC Healthcare和BJC的医疗系统的实时临床服务数据 协作网络，以监控政策、提供商实践、患者结果和进展 缩小癌症差距。 创新和影响。孵化器将致力于实现WU-ISCCC建设严谨、 快速周期实施研究的科学证据基础，以增加覆盖范围、外部有效性和 维持有效的癌症控制干预措施。我们将召集多部门合作伙伴，通报情况并采取行动 作为创新和有影响力的研究的环境，优先考虑农村和其他服务不足的社区。这个 孵化器将为即将到来的试点和方法研究的严格执行提供统计和数据支持 在研究计划之外，支持研究人员从概念化和规划到 传播。孵化器和我们多样化的成员的这些联系和活动将使吴- ISCCC将加快癌症控制和实施科学的创新、步伐和影响 缩小我区和全国癌症健康差距。